Is Johnson & Johnson (JNJ) a Buy on Sales Growth and Solid 2026 Guidance? [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
The new price target reflects 16 times the 2026 earnings estimate. Is Johnson & Johnson (JNJ) a Buy on Sales Growth and Solid 2026 Guidance? Gil C/Shutterstock.com According to the research firm, the upward re-rating reflects improving earnings prospects as the overall market rebounds. The search firm also expects additional banking deregulation to free up capital that would support a much higher valuation. The positive rating comes on the heels of Johnson & Johnson delivering impressive first-quarter 2026 results. The company posted a 9.9% sales growth in the quarter to $24.1 billion with adjusted earnings per share of $2.70. The company also increased its 2026 sales guidance to $100.3B-$101.3B from $100.0B-$101.0B. It also expects adjusted earnings per share of $11.45 to $11.65, representing 5.1% to 8.1% year-over-year growth. Johnson & Johnson (NYSE:JNJ) is a global healthcare company focused on researching, developing, and manufacturing innovative pharmaceutical produc
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- IMAAVY® (nipocalimab)?shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG) [Yahoo! Finance]Yahoo! Finance
- Is Johnson & Johnson (JNJ) the Best Counter Cyclical Stock to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- The Biggest Takeaway From ISRG Earnings [Forbes]Forbes
- BNO Strengthens Leadership Team for Next Phase of Growth and Innovation [Yahoo! Finance]Yahoo! Finance
- US to speed up payments for new medical devices under Medicare, FT reports [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/22/26 - Form 10-Q
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- JNJ's page on the SEC website